製品名: Atosiban
CAS番号: 90779-69-4
MF :C45H71N11O14S2
MW:994.19
カスタマイズされた: カスタマイズされた
に適しています: Lab Research
純度: >98%
応用: 医薬品
外観: 凍結乾燥粉末
Form: 粉
Atosiban, sold under the brand name Tractocile among others, is an inhibitor of the hormones oxytocin and vasopressin. 陣痛抑制剤として静脈内投与薬として使用されます。 (子宮収縮抑制性の) 早産を止めるために. It was developed by Ferring Pharmaceuticals in Sweden and first reported in the literature in 1985.Originally marketed by Ferring Pharmaceuticals, it is licensed in proprietary and generic forms for the delay of imminent preterm birth in pregnant adult women.
Atosiban is used to delay birth in adult women who are 24 に 33 weeks pregnant, when they show signs that they may give birth pre-term (prematurely).These signs include regular contractions lasting at least 30 seconds at a rate of at least four every 30 分,and dilation of the cervix (the neck of the womb) の 1 に 3 cm and an effacement (a measure of the thinness of the cervix) の 50% or more.In addition, the baby must have a normal heart rate.
